| 股號 / 名稱 | 營收 | 稅後淨利 |
| 6469 大樹 | 4,206,252,000 | 169,088,000 |
| 4104 佳醫 | 2,042,037,000 | 226,472,000 |
| 4175 杏一 | 1,836,693,000 | -2,102,000 |
| 5288 豐祥-KY | 1,775,154,000 | 259,267,000 |
| 6491 晶碩 | 1,725,121,000 | 514,985,000 |
| 6288 聯嘉 | 1,387,182,000 | 47,586,000 |
| 1565 精華 | 1,099,745,000 | 189,961,000 |
| 3218 大學光 | 1,071,180,000 | 298,489,000 |
| 4129 聯合 | 1,065,865,000 | 94,048,000 |
| 4116 明基醫 | 1,057,149,000 | 44,505,000 |
| 4745 合富-KY | 1,046,246,000 | 22,021,000 |
| 5312 寶島科 | 1,024,026,000 | 142,231,000 |
| 8403 盛弘 | 972,549,000 | 13,498,000 |
| 4121 優盛 | 951,402,000 | 9,487,000 |
| 4720 德淵 | 861,391,000 | 53,744,000 |
| 6782 視陽 | 815,946,000 | 169,222,000 |
| 4771 望隼 | 768,033,000 | 196,573,000 |
| 9919 康那香 | 718,797,000 | -94,318,000 |
| 4164 承業醫 | 657,618,000 | 1,378,000 |
| 4163 鐿鈦 | 603,125,000 | 85,109,000 |
| 5284 jpp-KY | 602,544,000 | -58,708,000 |
| 4126 太醫 | 563,985,000 | 107,651,000 |
| 4107 邦特 | 496,261,000 | 125,686,000 |
| 4737 華廣 | 468,473,000 | 11,305,000 |
| 1733 五鼎 | 450,658,000 | 29,124,000 |
| 4728 雙美 | 427,626,000 | 176,364,000 |
| 4138 曜亞 | 403,184,000 | 52,117,000 |
| 8109 博大 | 383,726,000 | 171,453,000 |
| 4155 訊映 | 352,277,000 | 38,893,000 |
| 6569 醫揚 | 275,340,000 | 50,048,000 |
| 1593 祺驊 | 242,939,000 | 4,628,000 |
| 4161 聿新科 | 219,814,000 | 17,695,000 |
| 1786 科妍 | 195,353,000 | 51,704,000 |
| 6747 亨泰光 | 190,130,000 | 49,039,000 |
| 6612 奈米醫材 | 161,001,000 | 13,363,000 |
| 1783 和康生 | 127,058,000 | 28,416,000 |
| 6762 達亞 | 100,301,000 | -2,583,000 |
| 4183 福永生技 | 97,901,000 | 11,789,000 |
| 4198 欣大健康 | 81,868,000 | -17,737,000 |
| 6598 ABC-KY | 81,502,000 | -63,120,000 |
| 6767 台微醫 | 74,590,000 | -14,762,000 |
| 6661 威健生技 | 68,420,000 | -5,668,000 |
| 6499 益安 | 47,141,000 | -214,513,000 |
| 4171 瑞基 | 45,905,000 | -21,525,000 |
| 5398 慕康生醫 | 38,851,000 | 1,499,000 |
| 6130 上亞科技 | 37,002,000 | -5,101,000 |
| 6733 博晟生醫 | 35,553,000 | -15,339,000 |
| 8409 商之器 | 26,906,000 | -21,941,000 |
| 6649 台生材 | 18,685,000 | -941,000 |
| 4188 安克 | 8,078,000 | -18,373,000 |
載入數據中...
